Pasadena Private Wealth’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
CCA
AWM
KF
OIA
CGA
Pasadena Private Wealth's BTAL Position: Q2 2026 in Review
Pasadena Private Wealth sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026, closing a stake of 2,286,833 shares — an estimated $31.9M sold.
Pasadena Private Wealth first reported a position in BTAL in Q1 2026 and held it in 1 quarter. The position peaked at $31.9M in Q1 2026. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- Pasadena Private Wealth reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2026 after selling out during the quarter.
- Pasadena Private Wealth sold 2,286,833 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $31.9M.
- Pasadena Private Wealth first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2026 and held it in 1 quarter.
- Pasadena Private Wealth's AGF US Market Neutral Anti-Beta Fund position peaked at $31.9M in Q1 2026.
- 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on Pasadena Private Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.